NYSE - Nasdaq Real Time Price USD

Eli Lilly and Company (LLY)

731.33

+5.02

(+0.69%)

At close: April 22 at 4:00 PM EDT

737.33

+6.00

(+0.82%)

Pre-Market: 7:49 AM EDT

Eli Lilly (LLY) Advances But Underperforms Market: Key Facts

Eli Lilly (LLY) concluded the recent trading session at $731.33, signifying a +0.69% move from its prior day's close.

Zacks 14 hours ago

LLY
+0.69%
Lilly to buy injectable drug plant in manufacturing ramp-up

The acquisition of a Nexus Pharmaceuticals facility in Wisconsin could help Lilly better meet demand for injectable medicines, like those it makes for diabetes and obesity.

BioPharma Dive 18 hours ago

LLY
+0.69%
NVO
+2.08%
Eli Lilly to acquire manufacturing facility from Nexus Pharma

Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals to produce injectable medicines. Lilly expects production at the facility based in Pleasant Prairie, Wisconsin, to begin at the end of 2025. Soaring demand for GLP-1 agonists, a class of highly effective diabetes and obesity drugs which suppress appetite and promote a feeling of fullness, has led to constrained supply for drugmakers such as Lilly and Danish drugmaker Novo Nordisk .

Reuters 20 hours ago

LLY
+0.69%
10 Best Performing Biotech ETFs in 2024

In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]

Insider Monkey 20 hours ago

LLY
+0.69%
EXAS

NBIX
11 Hot Growth Stocks To Buy Right Now

In this article, we discuss the 11 hot growth stocks to buy now. If you want to read about some more growth stocks that are active in the market, go directly to the 5 Hot Growth Stocks To Buy Right Now. As 2024 moves forward, the outlook for both the stock and bond markets undergoes […]

Insider Monkey yesterday

PLTR

SHOP

LLY
+0.69%
10 Best Healthcare Stocks to Buy Under $20

In this article, we will be taking a look at the 10 best healthcare stocks to buy under $20. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Best Healthcare Stocks to Buy Under $20. Global Healthcare Outlook for 2024 As 2024 progresses, the optimism surrounding the healthcare […]

Insider Monkey 2 days ago

RCM

NVST

OSCR
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential

Altimmune has a modest market cap but an incredibly promising GLP-1 drug.

Motley Fool 2 days ago

LLY
+0.69%
NVO
+2.08%
3 Relatively Safe Growth Stocks You Can Buy and Hold

Low risk and high-reward potential? These stocks could offer both.

Motley Fool 3 days ago

VRTX

LLY
+0.69%
NVO
+2.08%
Weight loss drugs and the many use cases in medical treatments

Novo Nordisk's (NVO) Ozempic and Wegouvy and Eli Lilly's (LLY) Zepbound are the leading names in the latest GLP-1 weight loss drug cycle, a trend that has seen a variety of use cases sprout up since these brand names' inceptions late last year. Yahoo Finance Health Reporter Anjalee Khemlani explains the new use cases being found for this class of drugs, including infertility treatments and even benefits for Alzheimer's patients. For more expert insight and the latest market action, click here to watch this full episode. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 3 days ago

NONOF

NVO
+2.08%
LLY
+0.69%
Eli Lilly Shares Show Healthy Rise

Eli Lilly and Company (LLY) shares are up in 2024 to the tune of 28% so far. Looking under the surface, it’s clear to see why this biopharmaceuticals stock is so powerful.

FX Empire 3 days ago

LLY
+0.69%
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data

J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.

Zacks 3 days ago

ABBV
+0.89%
LLY
+0.69%
ROG.SW
13 Best Low Volatility Stocks to Buy According to Hedge Funds

In this article, we discuss the 13 best low volatility stocks to buy according to hedge funds. To skip the detailed analysis of the current market conditions, go directly to the 5 Best Low Volatility Stocks to Buy According to Hedge Funds. The S&P 500 had a remarkable year in 2023 and the first quarter […]

Insider Monkey 4 days ago

^GSPC

^VIX

TSM
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher

ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.

Investor's Business Daily 4 days ago

RMD

LLY
+0.69%
NVO
+2.08%
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025

The GLP-1 class of drugs for weight loss has gained tremendous popularity but is struggling with a shortage that could extend into 2025. Who says that? The companies that make those drugs predict. The weight loss drug frenzy took off when the FDA approved Novo Nordisk A/S’s (NYSE:NVO) Wegvoy (semaglutide) in 2021. Eli Lilly And Co’s (NYSE:LLY) Zepbound (tirzepatide) appears to spur the momentum after receiving FDA approval in November 2023. According to the FDA, limited supplies of Eli Lilly’s d

Benzinga 4 days ago

LLY
+0.69%
India's Biocon developing its own version of Wegovy, clinical trial likely next year

Indian drugmaker Biocon , looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk's wildly popular Wegovy and is prepared to conduct a clinical trial next year if needed, the CEO told Reuters. Wall Street has forecast the market for this new generation of obesity treatments reaching at least $100 billion by the end of the decade, and Biocon is taking steps to be a part of that windfall. "We're going to develop semaglutide for India even if it requires a clinical trial," Chief Executive Officer Siddharth Mittal said in an interview of the active ingredient in Wegovy and Ozempic.

Reuters 4 days ago

BIOCON.NS

MITTAL.NS

NVO
+2.08%
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?

Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?

Investor's Business Daily 4 days ago

LLY
+0.69%
NVO
+2.08%
BIIB
-0.14%
Company News for Apr 18, 2024

Companies In The Article are: LLY,ADSK,MBLY,USB

Zacks 4 days ago

LLY
+0.69%
MBLY

ADSK
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies

Data from Eli Lilly's (LLY) SURMOUNT-OSA studies show that treatment with tirzepatide results in a mean AHI reduction of up to 63% in adults with obstructive sleep apnea and obesity.

Zacks 4 days ago

LLY
+0.69%
NVO
+2.08%
14 Best Large Cap Dividend Growth Stocks To Buy Now

In this article, we discuss 14 best large-cap dividend growth stocks to buy now. You can skip our detailed analysis of large-cap dividend stocks and their historical performance, and go directly to read 5 Best Large Cap Dividend Growth Stocks To Buy Now. Large-cap stocks have remained ideal for investors as they typically form the […]

Insider Monkey 4 days ago

UPS

AXP

TGT
2 Growth Stocks That Turned $10,000 Into More Than $100,000 in Just 10 Years

These stocks have taken different paths to where they are today, but both have been exceptional investments.

Motley Fool 5 days ago

TSLA

LLY
+0.69%

Performance Overview

Return	LLY	S&P 500
YTD	+25.68%	+5.05%
1-Year	+91.43%	+21.22%
3-Year	+297.04%	+20.06%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Eli Lilly and Company (LLY)

Eli Lilly (LLY) Advances But Underperforms Market: Key Facts

Lilly to buy injectable drug plant in manufacturing ramp-up

Eli Lilly to acquire manufacturing facility from Nexus Pharma

10 Best Performing Biotech ETFs in 2024

11 Hot Growth Stocks To Buy Right Now

10 Best Healthcare Stocks to Buy Under $20

Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential

3 Relatively Safe Growth Stocks You Can Buy and Hold

Weight loss drugs and the many use cases in medical treatments

Eli Lilly Shares Show Healthy Rise

Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data

13 Best Low Volatility Stocks to Buy According to Hedge Funds

How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher

Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025

India's Biocon developing its own version of Wegovy, clinical trial likely next year

Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?

Company News for Apr 18, 2024

Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies

14 Best Large Cap Dividend Growth Stocks To Buy Now

2 Growth Stocks That Turned $10,000 Into More Than $100,000 in Just 10 Years

Performance Overview